Benjamin Seeman, DO
Interventional Pain Medicine · Richmond, VANPI 1750426987
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Medtronic at 52.4% of the total. Reporting peaked in 2019 at $11,072 and has fallen 89.9% since, to $1,118 in 2025. Among interventional pain medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $58.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Stryker$1K
- Si-bone, Inc.$1K
- Pacira Pharmaceuticals Incorporated$1K
- Amgen$836
- Stimwave Technologies Incorporated$450
- plus $5K from 54 others
Across 1 payment — averaging $7255.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$7K
What the payments were for
- Consulting fees$1,6118%
- Speaking & faculty fees$5,01224%
- Travel & lodging$3,84918%
- Food & beverage$10,69751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$6,457
- Iovera$1,158
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$892
- INTELLIS ADAPTIVESTIM$861
- IFUSE IMPLANT SYSTEM$831
- INTELLIS$665
- Nalu Neurostimulation System$205
- ReActiv8$172
- AVAFLEX$145
- VERTAPLEX$145
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$134
- SYNCHROMED$134
- NUEDEXTA$125
- RESTORE$115
- INVEGA SUSTENNA$115
- Flexitouch Plus$104
- Entre Plus$104
How this compares
$21,169 in reported general payments places this provider in the 90th percentile of 52 interventional pain medicine providers in Virginia.
See all interventional pain medicine providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Richmond
- Yaoming GuRichmond$13K
- Daniel MartinRichmond$4K
- Elisabeth DoukliasRichmond$959
- Ketan PatelHaymarket$133K
- Che TorryNewport News$48K
- Niteesh BhararaReston$25K
- Sassan HassassianManassas$24K
- Raj SurejaNewport News$23K
- Alok GopalWinchester$16K
- Jacob LeeWinchester$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.